VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RMTI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RMTIRockwell Medical, Inc.
$0.59$23M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRMTICash Flow

Rockwell Medical, Inc. (RMTI) Cash Flow Statement

29Y historyFree accessUpdated daily

Liquidity remains under pressure as evidenced by the volatile free cash flow, which swung from a positive $2.2 million in 2025Q4 to a negative $592,000 in 2026Q1.

RMTI Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97
Cash from Operations2.66M-659K4.2M-9.41M-16.93M-33.53M-29.64M-27.25M-20.42M-21.11M-12.45M-16.24M4.26M-50.66M-30.75M-10.78M2.1M-1.43M-4.27M-3.4M-3.41M-493.52K1.03M225.42K-1.12M-920.02K-496.35K-900K-2.3M-1.2M
Operating CF Margin %--0.95%4.14%-11.26%-23.25%-54.15%-47.66%-44.46%-32.21%-36.85%-23.37%-29.34%7.86%-96.73%-61.69%-22.02%3.53%-2.61%-8.26%-7.9%-11.9%-1.78%5.72%1.51%-9.7%-10.2%-6.66%-13.43%-43.4%-36.36%
Operating CF Growth %157.37%-115.68%144.65%44.4%49.52%-13.13%-8.76%-33.47%3.29%-69.56%23.33%-481.44%108.4%-64.78%-185.14%-613.26%247.25%66.57%-25.6%0.25%-590.35%-148.08%355.39%120.21%-21.22%-85.36%44.85%60.87%-91.67%-
Net Income-1.61B-5.31M-480K-8.44M-18.68M-32.67M-30.89M-34.13M-32.13M-25.92M-19.8M-14.42M-21.33M-48.78M-54.02M-21.44M-2.68M-5.5M-7.86M-3.72M-4.57M76.81K211.52K4.85K-980.71K-1.58M-1.02M-1.1M-1.9M-1.9M
Depreciation & Amortization2.16M2.19M2.18M1.44M576K2.52M2.29M2.65M650.14K514.36K762.37K822.29K996.32K1.01M1.09M1.18M1.39M1.23M911.72K949.74K756.87K716.31K629.7K453.93K391.84K384.43K379.13K400K400K300K
Stock-Based Compensation914K1.82M1.29M932K315K943K475K4.95M4.39M7.17M10.35M8.89M10.09M7.71M7.3M4.38M4.02M403.2K1.46M00000000000
Deferred Taxes00000156K009M0-10.31M63.38K8.56K16.41K-7.22M21.56M2.7M36.41K000000000000
Other Non-Cash Items3.07M2.26M2.74M3.9M2.98M369K1.44M1.24M1.1M802.98K10.35M-2.91M1.76M452.12K7.3M-21.44M-2.68M1.95M-7.53K161.56K-4.54K0084.04K85K259.07K68.05K100K100K-100K
Working Capital Changes1.92M-1.61M-1.53M-7.24M-2.13M-4.84M-2.96M-1.98M-3.43M-3.68M-3.79M-8.68M12.73M-11.07M14.8M4.99M-645.96K451.47K1.24M-791.01K415.67K-1.29M185.32K-317.4K-611.41K15.58K73.28K-300K-900K500K
Change in Receivables599K-98K2.61M-4.64M-346K-1.74M32K2.78M-623.95K-962.34K-1.16M-574.73K106.32K-146.39K-209.12K284.48K-1.01M1.74M000000000000
Change in Inventory2.42M2.78M-332K1.18M-2.1M-656K-1.31M316.87K-835.64K343.49K-6.1M-3.95M-1.12M-150.01K-145.51K432.75K151.47K73.27K-602.57K101.05K-608.28K-399.36K-302.17K126.22K-409.98K-481.41K-171.88K-200K100K0
Change in Payables1.52M-870K-1.65M463K314K-416K1.14M-1.47M269.91K-1.64M1.86M-1.3M-3.39M-6.15M9.47M1.71M270.75K-1.82M000000000000
Cash from Investing-8.66M-8.54M-4.87M-3.04M-2.4M311K3.21M-4.75M12.72M14.5M-1.64M-21.14M-8.81M-12.65M11.52M-587.93K-12.92M-1.6M-1.26M-932.8K-1.01M-627.71K-475.14K-161.74K96.34K-1.68M-459.27K0-400K-600K
Capital Expenditures-904K-542K-1.01M-284K-281K-522K-1.05M-1.34M-994.26K-1.68M-355.26K-815K-684.59K-654.2K-507.79K-566.16K-772.36K-1.6M-1.27M-932.8K-1.01M-576.45K-392.05K-164.63K-381.9K-1.05M-304.53K0-400K-600K
CapEx % of Revenue0.01%0.78%1%0.34%0.39%0.84%1.68%2.18%1.57%2.94%0.67%1.47%1.26%1.25%1.02%1.16%1.3%2.93%2.46%2.17%3.54%2.08%2.18%1.1%3.32%11.59%4.08%-7.55%18.18%
Acquisitions175K00-12.36M0-833K0750K-250K7251K4.8K000-145.12K0000000000-4.74K000
Investments------------------------------
Other Investing0190K000833K0-750K250.4K7251K4.8K-8.12M6.9K1.58K148.11K1.8K09.55K00-51.26K-83.09K2.88K478.24K-633.9K-150K000
Cash from Financing4.22M4.25M7.35M11.34M16.15M-2.18M63.32M21.08M22M-2.16M80.16K2.78M58.47M70.48M18.22M4.82M46.73K20.47M27.9K12.77M6.78M1.25M-491.84K42.83K936.04K2.47M73.12K04.6M1.9M
Debt Issued (Net)-1.16M-1.19M-1.2M-3.51M-13.68M-2.28M21.74M-1.15M0000-21.1M18.89M-6.47K-18.21K-43.72K-181.45K-204.24K-396.33K-2.32M908.39K-530.53K5.12K-322.51K1.42M-6.23K0-200K-300K
Equity Issued (Net)7.82M7.82M10.18M14.86M30.02M107K45.45M23.88M22M123.6K80.16K-132.67K79.57M51.6M18.23M4.84M90.45K20.65M232.14K13.16M9.1M345.67K38.69K37.71K1.26M1.05M79.35K04.5M2.5M
Dividends Paid000000000000000000000000000000
Share Repurchases00000-6K-19K-279K0-2.29M0-2.91M0000000000000000-1.3M0
Other Financing-2.44M-2.37M-1.63M-5K-191K-6K-3.88M-1.65M3.5K-2.29M02.91M0000000000000000300K-300K
Net Change in Cash-1.78M-4.95M6.68M-1.12M-3.18M-35.4M36.89M-10.92M14.31M-8.77M-14.02M-34.6M53.92M7.17M-1M-6.55M-10.77M17.44M-5.5M8.43M2.36M132.84K59.56K106.51K-82.91K-127.76K-882.49K-800K4.6M1.9M
Free Cash Flow1.76M-1.2M3.19M-9.7M-17.21M-34.06M-30.69M-28.59M-21.41M-22.8M-12.81M-17.06M3.57M-51.32M-31.25M-11.35M1.33M-3.03M-5.54M-4.33M-4.42M-1.07M634.49K60.79K-1.5M-1.97M-800.88K-900K-2.7M-1.8M
FCF Margin %0.01%-1.73%3.14%-11.6%-23.64%-54.99%-49.34%-46.64%-33.78%-39.79%-24.04%-30.81%6.59%-97.98%-62.71%-23.18%2.23%-5.53%-10.72%-10.06%-15.43%-3.86%3.54%0.41%-13.02%-21.8%-10.74%-13.43%-50.94%-54.55%
FCF Growth %-18.66%-137.64%132.91%43.66%49.47%-10.98%-7.33%-33.52%6.07%-77.99%24.91%-577.33%106.96%-64.2%-175.39%-954.26%143.88%45.33%-27.85%2.01%-313.12%-268.63%943.7%104.06%23.81%-145.37%11.01%66.67%-50%-
FCF per Share0.04-0.030.10-0.42-1.74-3.99-4.46-5.16-4.46-4.93-2.77-3.770.95-17.13-16.86-7.040.87-2.24-4.40-4.10-4.36-1.340.660.07-2.13-3.75-1.81-1.98-6.13-4.01
FCF Conversion (FCF/Net Income)-0.00x0.12x-8.75x1.12x0.91x1.03x0.96x0.80x0.64x0.81x0.63x1.13x-0.20x1.04x0.57x0.50x-0.78x0.26x0.54x0.91x0.74x-6.43x4.85x46.45x1.14x0.58x0.49x0.82x1.21x0.63x
Interest Paid190K0847K1.21M1.47M01.56M00000000000000000000000
Taxes Paid0000000000404.53K0000000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and Revenue Erosion

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality and Cash Disconnect

As reported in recent quarterly filings, RMTI exhibits a volatile relationship between net income and operating cash flow, with the OCF/NI ratio fluctuating wildly from 0.00 to 4.20, suggesting that accounting accruals and working capital swings are currently masking the underlying cash-generative capacity of the business.

The frequent divergence between net losses and operating cash flow indicates that the company's reported earnings are heavily influenced by non-cash items and timing differences in receivables. Investors should monitor whether this volatility reflects genuine operational instability or merely the lumpy nature of collections from a concentrated customer base.

Free Cash Flow Volatility Persists

Based on the provided cash flow statements, RMTI's free cash flow trajectory remains highly inconsistent, swinging from a positive $2.2 million in 2025Q4 to a negative $592,000 in 2026Q1, which underscores the difficulty in maintaining self-sustaining operations amidst a contracting revenue base and persistent net losses.

The inability to maintain a positive FCF margin suggests that the company's core business model is not yet optimized for cash generation. This erratic performance may indicate that management is struggling to balance necessary operational expenditures with the need to preserve a dwindling cash runway.

Working Capital Swings Drive Liquidity

According to the company's historical cash flow data, working capital changes have been a primary driver of quarterly cash flow, with a significant $3.7 million outflow in 2025Q1 followed by a $1.4 million inflow in 2025Q4, highlighting the sensitivity of RMTI's liquidity to customer payment cycles.

The reliance on working capital fluctuations to bridge cash flow gaps suggests that the company lacks a stable, organic source of operating cash. This dependency warrants further investigation into the credit quality of its primary dialysis provider customers and the potential for future bad debt expenses.

Hidden Costs and Cash Dilution

As indicated by the financial statements, the company's cash flow is consistently impacted by stock-based compensation, which reached $532,000 in 2025Q3, effectively acting as a non-cash expense that masks the true economic cost of operations while simultaneously diluting the equity base of existing shareholders.

While stock-based compensation does not directly consume cash, it represents a significant hidden cost that complicates the assessment of true profitability. The persistent issuance of equity-based incentives during periods of negative cash flow suggests a misalignment between management compensation and the company's current financial reality.

RMTI — Frequently Asked Questions

Quick answers to the most common questions about buying RMTI stock.

How much cash does Rockwell Medical, Inc. (RMTI) generate from operations?

Rockwell Medical, Inc. (RMTI) generated $-0.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Rockwell Medical, Inc.'s free cash flow?

Rockwell Medical, Inc. (RMTI) reported negative free cash flow of $1.2M in 2025, indicating capital requirements exceeded cash from operations.

What is Rockwell Medical, Inc.'s capital expenditure (CapEx)?

Rockwell Medical, Inc. (RMTI) spent $0.5M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.